血清阳性关节痛进展为类风湿关节炎的一年预测因素:Reuma-Check项目大型队列研究
在阿根廷Reuma-Check前瞻性队列的1730例患者中,208例(12%)为血清阳性关节痛(SA),225例(13%)为类风湿关节炎(RA)。随访1年,21%的SA患者进展为RA,14%发展为其他免疫介导疾病,65%保持稳定。多变量分析显示,ACPA阳性是SA进展为RA的唯一独立预测因素(OR: 7.7, 95% CI: 1.2-60)。
要点
- 在1730例早期关节炎队列中,血清阳性关节痛(SA)占12%,类风湿关节炎(RA)占13%。
- 随访1年,21%的SA患者进展为RA,14%发展为其他免疫介导疾病,65%保持稳定。
- ACPA阳性是SA进展为RA的唯一独立预测因素(OR: 7.7, 95% CI: 1.2-60)。
核心结论
- 在Reuma-Check队列中,血清阳性关节痛个体中ACPA阳性是1年内进展为类风湿关节炎的最稳健预测因素。
研究设计与样本
- 本研究为前瞻性研究,在阿根廷Reuma-Check早期风湿病评估结构化诊断项目内开展,共纳入1730例患者,其中208例为血清阳性关节痛(SA),225例为类风湿关节炎(RA),SA患者随访12个月,采用 logistic 回归分析RA进展的独立预测因素。
主要发现
- 与RA患者相比,SA患者压痛关节数和肿胀关节数更少,炎症标志物水平更低,超声能量多普勒阳性率更低。
- 随访1年,21%的SA患者进展为RA,14%发展为其他免疫介导疾病,65%保持稳定。
- 多变量分析中,ACPA阳性是SA进展为RA的唯一独立预测因素(OR: 7.7, 95% CI: 1.2-60)。
关键数值与推荐
- 血清阳性关节痛(SA)定义为类风湿因子(RF)和/或抗环瓜氨酸蛋白抗体(ACPA)阳性个体中无临床滑膜炎的关节疼痛。
- 1年随访时,21%的SA患者进展为RA,14%发展为其他免疫介导疾病,65%保持稳定。
- ACPA阳性预测SA进展为RA的OR为7.7(95% CI: 1.2-60)。
临床怎么用
- 在血清阳性关节痛患者中,检测ACPA阳性有助于识别1年内进展为类风湿关节炎的高风险个体。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seropositive arthralgia (SA), defined as joint pain without clinical synovitis in individuals positive for rheumatoid factor (RF) and/or anti-citrullinated protein antibodies (ACPA), is considered a preclinical stage of rheumatoid arthritis (RA). Early identification of individuals at risk is key for timely intervention. OBJECTIVES: To estimate the prevalence of SA in a large early arthritis cohort, compare its baseline features with RA, and identify predictors of progression to RA at one year. METHODS: This prospective study was conducted within Reuma-Check, a structured diagnostic program for early rheumatologic assessment in Argentina. Patients with SA and RA were identified based on standardized clinical, serological, and imaging assessments. SA patients were followed for 12 months. Logistic regression was used to identify independent predictors of RA development. RESULTS: Among 1730 patients, 208 (12%) were classified as SA and 225 (13%) as RA. Compared to RA, SA patients had fewer tender and swollen joints, lower inflammatory markers, and less Power Doppler positivity on ultrasound. At one year, 21% of SA patients progressed to RA, 14% developed other immune-mediated conditions, and 65% remained stable. In multivariate analysis, ACPA positivity was the only independent predictor of RA progression (OR: 7.7, 95% CI: 1.2-60). CONCLUSIONS: In the Reuma-Check cohort, among individuals with seropositive arthralgia, ACPA positivity is the most robust predictor of progression to rheumatoid arthritis at 1 year.
引用
- Garcia-Salinas R, MeJia-Maggi N, Almada F, et al. Progression from seropositive arthralgia to rheumatoid arthritis: One-year predictors from a large cohort in the Reuma-Check program. Semin Arthritis Rheum. 2025. PMID: 41275572. doi:10.1016/j.semarthrit.2025.152881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。